FDA 510(k)

ISE indireto K para Gen.2; ISE indireto Na para Gen.2; ISE indireto Cl para Gen.2; cobas pro soluções integradas

Número K: K253491 · 2026-02-12

Data da decisão2026-02-12

Código do produtoCEM

Comité consultivoCH

DecisãoSubstantially Equivalent

Resumo do dispositivo

ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions is the device name listed in this FDA 510(k) record. The listed applicant is Roche Diagnostics. It received FDA 510(k) clearance on 2026-02-12 under 510(k) number K253491. The device is classified under product code CEM. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions?

ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions is a medical device that received FDA 510(k) clearance on 2026-02-12. The listed applicant is Roche Diagnostics. The 510(k) number is K253491.

When did ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions receive FDA 510(k) clearance?

ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions received FDA 510(k) clearance on 2026-02-12, under 510(k) number K253491.

Who is the listed applicant for ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions?

The FDA 510(k) record lists Roche Diagnostics as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions?

The FDA product code for ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions is CEM.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Roche Diagnostics como candidato(a)

K261686Elecsys Phospho-Tau (217P) Plasma K252323cobas pulse blood glucose monitoring system K252280Elecsys Anti-SARS-CoV-2 S K260049Elecsys Anti-HBc IgM K260048Elecsys Anti-HAV IgM K260046Elecsys Anti-HBc II

Ver todos os 69 dispositivos →

Dispositivos Relacionados (Código: CEM)

K241037ABL90 FLEX PLUS SistemaRadiometer Medicals Aps K220396EasyStat 300Medica Corporation K230890ISE ElectrodesRandox Laboratories, Ltd.K200544SmartLyte® Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+Diamond Diagnostics, Inc.

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.